NK cells engineered with an anti-CD73 CAR effectively killed CD73+ lung adenocarcinoma A549 cells when engineered with either mRNA or lentivirally transduced, showing that both transient and stable expression of the gene is enough to produce NK cell based anti-tumor effects. The gene discussed is NT5E; the disease is lung adenocarcinoma.